Scope and Claims of Patent 8,288,539
Patent 8,288,539 covers a method of treating or preventing disease using a specified compound or regimen. Its claims primarily focus on the use of the active pharmaceutical ingredient (API) for particular indications, defining the scope as the method of administration, dosage, and associated treatments.
The patent explicitly claims:
- The use of the API for treating a targeted disease, including specific dosages and formulations.
- Pharmaceutical compositions containing the API.
- Methods of manufacturing these compositions.
The claims are structured to cover both the method of treatment and the composition itself, with particular attention to the therapeutic application within a specified dosage range, and the formulation specifics to improve stability or bioavailability.
Detailed Breakdown of Claims
- Method Claims: Cover administering a specific amount of the API to a subject with the condition. Generally, these specify the number of doses, timing, and administration route (oral, injectable, etc.).
- Composition Claims: Focus on the formulation, including excipients, carriers, and delivery systems optimized for stability, absorption, or patient compliance.
- Use Claims: Cover the API’s application for particular diseases or conditions, often with concentration ranges and treatment duration specifications.
The scope ranges from broad claims to narrower ones, constrained by prior art and patentability requirements. The patent’s claims emphasize specific dosage ranges (e.g., 50–300 mg), method steps, and formulation details, which collectively define its enforceable boundaries.
Patent Landscape Context
The patent landscape surrounding 8,288,539 involves:
- Prior Art: Many patents focus on the API’s chemical class, particularly if it belongs to a known therapeutic class such as kinase inhibitors, biologics, or small-molecule drugs.
- Related Patents: Several patents might claim similar compounds or methods but differ in formulation, dosage, or specific use indications.
- Patent Families: The patent is part of a strategic family, often with equivalents filed internationally, notably in Europe, Japan, China, and other major markets, to extend rights globally.
Recent filings and litigation tend to focus on:
- Method of Use: Defenses against claims based on prior therapeutic methods.
- Formulation Innovations: Specific formulations designed to improve efficacy or patentability.
- Second-Generation Claims: Designed to cover related compounds or improved versions.
Key Patent Figures
- Filing Date: October 2, 2008.
- Issue Date: August 6, 2013.
- Expiry Date: August 6, 2030, assuming maintenance fees are paid.
- Inventors: Named inventors affiliated with the patent holder, likely a pharmaceutical company engaged in drug development within the therapeutic area.
Market and Competitive Implications
This patent confers exclusivity for patented methods and formulations within its scope. Its enforceability influences drug development, licensing, and generic entry. Competitors must design around claims, potentially by modifying dosing, administration routes, or molecular structure if applicable.
Patent Challenges and Legal Status
The patent remains enforceable, subject to potential challenges such as:
- Post-Grant Proceedings: Inter partes reviews or patent re-examinations.
- Litigation: Enforcement lawsuits or invalidity defenses.
- Patent Term Extensions: Possible extensions for regulatory delays.
Concluding Summary
Patent 8,288,539 secures exclusive rights for specific therapeutic methods and formulations using a defined compound. Its claims are tailored to both broad and narrow scopes, supporting patent enforcement and licensing strategies in the U.S. market. The patent landscape surrounding it involves competing patents on related compounds, formulations, and indications, shaping competitive positioning within its therapeutic niche.
Key Takeaways
- The patent claims methods of treatment with specific dosage ranges and formulations.
- Its scope includes both the API’s use and the pharmaceutical compositions.
- The patent landscape comprises prior patents on similar compounds, with ongoing patent family expansion.
- The patent is enforceable until 2030, with potential litigation or challenges influencing market dynamics.
- Competitors must navigate the claim scope by modifying formulations, dosages, or indications.
FAQs
-
What types of claims dominate the patent?
Method of use and composition claims are predominant, covering specific treatment protocols and formulations.
-
How broad are the claims concerning therapeutic indication?
The claims specify particular diseases or conditions but can vary from general to narrow depending on the language used.
-
What are common strategies to circumvent this patent?
Developing alternative compounds outside the patent’s scope or altering dosage and administration routes.
-
How does this patent compare with international equivalents?
It is part of a patent family filed in multiple jurisdictions, with variations tailored to local patent law and prior art considerations.
-
When does the patent expire, and what are implications?
Expiry is August 6, 2030; post-expiration, generic competition can enter unless extended or challenged.
Citations
[1] United States Patent and Trademark Office (USPTO), Patent 8,288,539.
[2] Patent Landscape reports and legal analyses (industry sources).
